Update on active specific immunotherapy with melanoma vaccines.

about

Clinical implications of the new biology in the development of melanoma vaccines.Susceptibility to the biological effects of polyaromatic hydrocarbons is influenced by genes of the major histocompatibility complex.

P2860

Q33603062-117AE986-6695-40F6-9B29-F86203CCC7E9 Q36758009-1DA8DB20-4AA4-41D3-AB3E-84868A24BF73

P2860

Update on active specific immunotherapy with melanoma vaccines.

Item

http://www.wikidata.org/entity/Q41589321

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Update on active specific immunotherapy with melanoma vaccines.

@en

type

Item

label

Update on active specific immunotherapy with melanoma vaccines.

@en

prefLabel

Update on active specific immunotherapy with melanoma vaccines.

@en

P1476

Update on active specific immunotherapy with melanoma vaccines.

@en

P2093

Conforti AM

http://www.w3.org/2001/XMLSchema#string

Gammon G

http://www.w3.org/2001/XMLSchema#string

Kelley MC

http://www.w3.org/2001/XMLSchema#string

Morton DL

http://www.w3.org/2001/XMLSchema#string

Ollila DW

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma

Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene.

Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

P304

55-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/(SICI)1096-9098(199709)66:1<55::AID-JSO12>3.0.CO;2-N

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1997-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9290695

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Update on active specific immunotherapy with melanoma vaccines.

about

P2860

P2860

Update on active specific immunotherapy with melanoma vaccines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921